Waterford, Ireland

Orla O'Donovan

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Orla O'Donovan: Innovator in Ocular Drug Delivery

Introduction

Orla O'Donovan is a prominent inventor based in Waterford, Ireland. She has made significant contributions to the field of ocular drug delivery, focusing on innovative solutions to enhance therapeutic efficacy. Her work is particularly relevant in the context of treating eye disorders, where effective delivery systems are crucial.

Latest Patents

Orla O'Donovan holds a patent for her invention related to ocular drug delivery. The patent describes a Nanostructured Lipid Carrier (NLC) particle that encapsulates a therapeutic agent for ocular delivery. This innovative carrier comprises a solid outer shell made of solid lipid and a liquid core containing a liquid lipid, which houses the therapeutic agent. The patent also covers compositions of the NLC particles, their applications, methods for treating or preventing eye disorders, and an eye drop dispenser.

Career Highlights

Orla O'Donovan is affiliated with the Waterford Institute of Technology, where she continues to advance her research in drug delivery systems. Her work has garnered attention for its potential to improve patient outcomes in ocular therapies.

Collaborations

Orla collaborates with notable colleagues, including Gautam Behl and Sangeeta Kumari, who contribute to her research endeavors and help drive innovation in the field.

Conclusion

Orla O'Donovan's contributions to ocular drug delivery exemplify the impact of innovative thinking in healthcare. Her patented technology represents a significant advancement in the treatment of eye disorders, showcasing her dedication to improving therapeutic delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…